Key facts
- This page summarizes Ivan Tornos's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Feb 2024, 20:58.
Ivan Tornos - 25 Feb 2024 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- ZBH
- Reported as of
- 25 Feb 2024
- Net transaction value
- -$390,006
- SEC form
- 4
- Accepted by SEC
- 27 Feb 2024, 20:58:04 UTC
- Prior SEC filing
- 22 Feb 2024
- Next SEC filing
- 08 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew R. St. Louis, Attorney-in-Fact for Ivan Tornos (power of attorney previously filed
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ivan Tornos filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 27 Feb 2024.
Change
- Previous filing in this sequence was filed on 22 Feb 2024.
- Current net transaction value: -$390,006.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZBH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +7,513
- Change %
- +43%
- Price
- $0.000000
- Shares after
- 25,153
- Date
- 25 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
ZBH
transaction
Common Stock
Tax liability
- Transaction value
- $390,006
- Shares
- -3,028
- Change %
- -12%
- Price
- $128.80
- Shares after
- 22,125
- Date
- 25 Feb 2024
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZBH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -7,513
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 25 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,513
- Exercise price
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.
Footnote F2
Includes 121 shares acquired under the Company's Employee Stock Purchase Plan through February 1, 2024.
Footnote F3
Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.
Footnote F4
Each RSU represents a contingent right to receive one share of Company common stock.